SecBot SecBot
144 ·Filed Nov 2, 2026

PCVX

Vaxcyte, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed14d 5h ago SEC0001969223-26-001113
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small relative to market cap and appears to be a routine exercise-and-sell of stock options. However, the officer's prior sale of 19,000 shares in early October suggests a pattern of periodic monetization. Monitor for any acceleration of insider selling ahead of upcoming catalysts.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$60.81
T+0 close · Nov 2, 2026 · via day close
Latest settled
+9.13%
T+5 · $66.36 · next T+20 in 15d
Vs SPY
+9.71%
α at T+5
Latest observation
+4.75%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $60.81entry
  2. T+1 · 13d ago +8.01%α +6.36% · $65.68
  3. T+5 · 7d ago +9.13%α +9.71% · $66.36
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Elvia Cowan, an officer of Vaxcyte, filed a Form 144 notice of intent to sell 3,000 shares of common stock, with an estimated aggregate market value of $185,640. The shares were acquired via exercise of stock options on the same date. The filing also notes a prior sale of 19,000 shares on October 5, 2026, for approximately $1.65 million, indicating a pattern of insider selling.

Key Facts

  • Officer Elvia Cowan filed Form 144 to sell 3,000 shares of Vaxcyte common stock.
  • Estimated aggregate market value of proposed sale: $185,640.
  • Shares were acquired on 11/02/2026 via exercise of stock options.
  • A prior sale of 19,000 shares occurred on 10/05/2026 for approximately $1,648,060.
  • Total insider selling over the past 30 days (including this filing) is approximately $1.83M.
  • Market cap of Vaxcyte is $9.9B; the proposed sale represents ~0.002% of market cap.

Financial Impact

Proposed sale of 3,000 shares valued at $185,640, representing a negligible fraction of the company's $9.9B market cap.

dilutioninsider ownership

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • Insider selling pattern could signal reduced conviction if it continues at elevated levels.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-001113
Document: 0001969223-26-001113-index.html0001969223-26-001113
Document: 0001969223-26-001113.txt0001969223-26-001113

Track record

29 reports on PCVX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +10.87% at T+5 after the Oct 8, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.40 Now $63.37 +1.55% settles Dec 15
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $64.69 Now $63.37 −2.04% settles Dec 11
  3. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $63.37 −0.81% settles Dec 7
  4. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $63.37 −0.81% settles Dec 7
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $61.92 Now $63.37 +2.34% settles Dec 4
  6. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $61.92 Now $63.37 +2.34% settles Dec 4
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $63.37 +4.21% settles Dec 2
  8. Nov 2, 202614d ago 144 Neutral 2/10 Viewing Entry $60.81 Now $63.37 +4.21% settles Dec 2
  9. Oct 9, 20265w ago 8-K Bearish 6/10 Entry $70.65 to $67.53 Now $63.37 +10.30% ▲ +4.42% +1.15% vs SPY
  10. Oct 8, 20265w ago 424B5 Bearish 6/10 Entry $71.38 to $63.89 Now $63.37 +11.22% ▲ +10.49% +4.93% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Wed (12h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026